Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series
Open Access
- 16 April 2024
- journal article
- letter
- Published by Frontiers Media SA in Transplant International
- Vol. 37, 12778
Abstract
Belatacept in Pancreas Transplantation: Promising Insights From a Cohort SeriesKeywords
This publication has 5 references indexed in Scilit:
- A Multi-Modal Approach to Islet and Pancreas Transplantation With Calcineurin-Sparing Immunosuppression Maintains Long-Term Insulin Independence in Patients With Type I DiabetesTransplant International, 2023
- Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunctionPLOS ONE, 2020
- Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trialAmerican Journal of Transplantation, 2020
- Tacrolimus- versus sirolimus-based immunosuppression after simultaneous pancreas and kidney transplantation: 5-year results of a randomized trialAmerican Journal of Transplantation, 2020
- Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic ParametersTransplantation Direct, 2019